FSD Pharma Stock Forum

$FSD Pharma(HUGE.US)$ epic dilution to fund the"innovative" ventures

$FSD Pharma(HUGE.US)$ FSD Pharma Enters Exclusive Option Agreement With University Of Southern California To Evaluate Dietary Supplement Technology For Commercialization

$FSD Pharma(HUGE.US)$
FSD Pharma Receives Institutional Review Board Approval to Study the Safety and Efficacy of Unbuzzd(TM) in Acute Alcohol Intoxication
FSD Pharma has received Institutional Review Board (IRB) approval for its METAL-2 trial in the USA to study the safety and efficacy of Unbuzzd(TM) in acute alcohol intoxication. This approval allows the company to begin recruiting participants and planning the clinical study. Dr. Andrzej Chruscinski, Vice-President of Clinical and Scienti...

$FSD Pharma(HUGE.US)$
FSD Pharma Submits a Clinical Trial Protocol to Study the Safety and Efficacy of Unbuzzd(TM) in Acute Alcohol Intoxication

$FSD Pharma(HUGE.US)$
NEWS
FSD Pharma Submits a Phase-1 Multiple Ascending Doses Clinical Trial Application for Lucid-21-302 (Lucid-MS) for Ethics Committee Review in Australia

$FSD Pharma(HUGE.US)$
NEWS
FSD Pharma Signs Agreement with Applied Science and Performance Institute (ASPI) to Conduct a Clinical Trial in the United States to Assess the Safety and Efficacy of unbuzzd(TM) in an Induced State of Alcohol Intoxication

$FSD Pharma(HUGE.US)$ This sure was a disappointment! But its green! And thats sure better than red by any amount

$FSD Pharma(HUGE.US)$ FSD Pharma Provides Update From Celly Nu's Partnership With Six+One For Beverage Product Unbuzzd
Benzinga· 8 mins ago
On April 25, 2024, Celly Nu announced a strategic partnership with Six+One, a purpose-driven branding, advertising, and production agency based in New York City.
FSD Pharma has also licensed unbuzzd, a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of quickly relieving indiv...

$FSD Pharma(HUGE.US)$
NEWS
FSD Pharma Inc. received a notification from Nasdaq regarding non-compliance with the minimum bid price requirement, giving them a 180-day compliance period to meet the requirement or face potential delisting.